Apyx Medical
APYX
61 hedge funds and large institutions have $87.7M invested in Apyx Medical in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 12 closing their positions.
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
9% more funds holding
Funds holding: 56 → 61 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
6% less capital invested
Capital invested by funds: $93.1M → $87.7M (-$5.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$947K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$793K |
| 3 |
Barclays
London,
United Kingdom
|
+$748K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$670K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$604K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.25M |
| 2 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$847K |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$753K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$710K |
| 5 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$574K |
APYX Hedge Fund Activity: Q4 2018 in Review
61 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2018, worth a combined $87.7M — down 5.8% from $93.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new APYX positions and 12 closed out — a net gain of 6 holders — while 16 added to existing stakes and 17 trimmed.
The largest buyer was RTW Investments, adding an estimated $947K. The largest seller was Geode Capital Management, exiting entirely with an estimated $1.25M sold.
- 61 institutional investors held Apyx Medical (APYX) as of Q4 2018, up from 56 in Q3 2018.
- Funds reported $87.7M of Apyx Medical stock for Q4 2018, down 5.8% quarter-over-quarter.
- 18 funds opened new Apyx Medical positions in Q4 2018 and 12 closed out, a net change of +6 holders.
- The largest Apyx Medical buyer in Q4 2018 was RTW Investments, an estimated $947K added.
- The largest Apyx Medical seller in Q4 2018 was Geode Capital Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q4 2018.